+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

G

Actively Recruiting

Researchers are evaluating clinical outcomes in patients with difficult to treat depression, including those with treatment resistant depression, who receive Vagus Nerve Stimulation VNS Therapy as an additional treatment. The study focuses on patients diagnosed with unipolar or bipolar disorder with chronic or recurrent depression who have not responded well to standard psychiatric care. Diagnosis and comorbid conditions are confirmed using the Mini International Neuropsychiatric Interview MINI. Participants will be implanted with a VNS Therapy System, which includes an implantable generator, lead, and external programming system. The study plans to enroll at least 500 patients across up to 80 sites globally. Each participant will have a baseline visit 1 to 6 weeks before the implant procedure. After implantation, participants will be followed for a period ranging from 36 to 60 months, with the study concluding once the last patient completes 36 months of follow-up. During the study, participants will attend outpatient clinic visits to complete evaluations based on the study protocol. Researchers will measure changes in depression symptoms using the Montgomery sberg Depression Rating Scale MADRS at 12 months as the primary outcome. Secondary outcomes include changes in mood, quality of life, function, suicidality, cognition, anxiety, and treatment adjustments, monitored for an average of 4 years. Safety and tolerability will also be assessed through tracking adverse events.

Age: 18Years +All Genders
18 locations